Skip to Main Content

Author Details

Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
1983
306
68
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36562628Transcriptomic pan-cancer analysis using rank-based Bayesian inference.Mol Oncol2023
37760629MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.Cancers (Basel)2023
37503126Understanding the genetic complexity of puberty timing across the allele frequency spectrum.medRxiv2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
37309009Buffy coat signatures of breast cancer risk in a prospective cohort study.Clin Epigenetics2023
36587134Analysis of Spatial Molecular Data.Methods Mol Biol2023
36833223<i>ABCB1</i> Amplicon Contains Cyclic AMP Response Element-Driven <i>TRIP6</i> Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines.Genes (Basel)2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
36706086High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.PLoS One2023
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35350772Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer.NAR Cancer2022
35440061Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers.Epigenetics Chromatin2022
35751095DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.Breast Cancer Res2022
36477895Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers.Nucleic Acids Res2022
36531044Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy.Front Oncol2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
36093296Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.Oncotarget2022
36156150A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours.Nucleic Acids Res2022
35256859miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy.Breast Cancer (Dove Med Press)2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
35267636Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer.Cancers (Basel)2022
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33566819miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.PLoS Comput Biol2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
34554372Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.Breast Cancer Res Treat2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
34508103Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3<sup>VNTR</sup> polymorphisms and gene co-expression.NPJ Breast Cancer2021
34069208Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?Cancers (Basel)2021
34035375MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro.Sci Rep2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
33434192Efficient gene expression signature for a breast cancer immuno-subtype.PLoS One2021
33361113Modeling molecular development of breast cancer in canine mammary tumors.Genome Res2021
31444972Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.Int J Cancer2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33457104Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.Oncoimmunology2020
33139755Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer.Sci Rep2020
32710281Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer.Breast Cancer Res Treat2020
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
32671987Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.Cancer Rep (Hoboken)2020
32208873Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.Acta Oncol2020
32488909Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.Int J Cancer2020
32370743MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers.BMC Cancer2020
31529022Subtype-specific transcriptional regulators in breast tumors subjected to genetic and epigenetic alterations.Bioinformatics2020
30685436A Computational Framework for Genome-wide Characterization of the Human Disease Landscape.Cell Syst2019
  • 1 - 50 of 306

Recommended Authors

Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 9
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 52
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 6
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 10
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 3
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 6
Teresa Ram??n y Cajal
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 91
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 20
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 4
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 67
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 11
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 17
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 21
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 7
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 4
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 4
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 8
Martin Widschwendter
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Career Start Year 1993
Number of shared co-authors 85
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 11
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 28
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 12
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 31
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 8
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 1
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 72
Mark A Watson
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 6
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 10
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 73

Collaborators

Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 164
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 92
Douglas F Easton
University of Cambridge
Co-authored papers 92
Per Hall
Co-authored papers 92
Alison M Dunning
Co-authored papers 91
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 90
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 88
Fergus J Couch
Mayo Clinic
Co-authored papers 87
Graham G Giles
Co-authored papers 85
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 81
Irene L Andrulis
University of Toronto
Co-authored papers 77
Diether Lambrechts
Co-authored papers 77
Roger L Milne
Co-authored papers 74
Christopher A Haiman
University of Southern California
Co-authored papers 70
Jan Lubinski
Pomeranian Medical University
Co-authored papers 70
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 70
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 69
Hoda Anton-Culver
University of California irvine
Co-authored papers 67
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 64
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 61
Loic Le Marchand
Co-authored papers 58
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 55
Wei Zheng
Co-authored papers 53
Janet E Olson
Mayo Clinic
Co-authored papers 51
Julia A Knight
Co-authored papers 47
Børge G Nordestgaard
Co-authored papers 46
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 44
Xiao-Ou Shu
Co-authored papers 40
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 38
Anna H Wu
University of Southern California
Co-authored papers 35
Release 1.2